Further study has shown NUPR1 may inhibit the progress of DLBCL by involving the immune response, and TRIB3 should be a carcinogenic gene in DLBCL through regulating ER stress. This evidence concerns the gene TRIB3 and diffuse large B-cell lymphoma.